Proactive Digital Therapeutics in Diabetology: Fusing Predictive Analytics, Continuous Glucose Forecasting, and Conversational AI in a Mobile Paradigm

Abstract

The global prevalence of diabetes necessitates a paradigm shift from reactive treatment to proactive, data-driven chronic disease management. This paper presents the conceptualization and architecture of a novel Android mobile application designed to provide comprehensive diabetes care through predictive analytics and personalized patient engagement. The application integrates a suite of artificial intelligence and machine learning (AI/ML) models to execute three primary clinical tasks: diabetes risk stratification (utilizing Random Forest, XGBoost, and Logistic Regression), continuous blood glucose trend prediction (employing Long Short-Term Memory networks), and dynamic diet recommendation (combining rule-based algorithms with an ML hybrid approach). To bridge the gap between complex algorithmic outputs and patient comprehension, the application features an integrated conversational chatbot that delivers personalized guidance and real-time clinical explanations. By translating high-dimensional physiological data into actionable outpatient metrics, this mobile health solution empowers patients while simultaneously streamlining clinical workflows.

Introduction

Diabetes mellitus is a serious global health problem characterized by high blood sugar levels and metabolic disorders. Traditional diabetes care depends mainly on periodic doctor visits and retrospective data analysis, which often leads to delayed treatment decisions, poor patient monitoring, and inadequate blood glucose control. Patients also face treatment fatigue due to limited real-time feedback. Therefore, there is a need to bridge the gap between clinical visits and continuous patient self-management.

Mobile health (mHealth) technologies provide a solution by enabling continuous monitoring and proactive diabetes management. The proposed system is an Android-based mobile application that integrates artificial intelligence and machine learning to analyze physiological data and provide real-time clinical insights. The application performs three main tasks: diabetes risk prediction, continuous glucose trend forecasting, and personalized dietary recommendations.

For diabetes risk prediction, the system uses machine learning models such as Random Forest, XGBoost, and Logistic Regression to analyze health factors like body mass index, blood pressure, glucose levels, and physical activity. These models classify patients into low, medium, or high-risk categories. For real-time glucose monitoring, the system processes data from Continuous Glucose Monitors (CGM) using a Long Short-Term Memory (LSTM) neural network, which can analyze time-series data and predict future glucose levels. Based on these predictions, the application provides personalized dietary advice through a hybrid recommendation system that combines medical rules with machine learning.

To improve patient understanding and engagement, the system includes a conversational chatbot that translates complex predictions into simple guidance. The chatbot explains dietary recommendations, warns users about possible glucose spikes, and answers health-related questions.

The system architecture includes a React Native mobile interface, backend microservices, and machine learning models connected through APIs. Real-time glucose data is streamed using WebSocket connections, allowing instant updates of predictions, diet recommendations, and chatbot responses.

Expected results show that ensemble machine learning models can achieve high prediction accuracy, while the LSTM model can forecast glucose changes 30–60 minutes in advance, allowing preventive action. The chatbot further improves patient adherence by providing understandable and personalized guidance.

Conclusion

The development and implementation of this intelligent Android-based mobile application represents a critical paradigm shift in the digital management of diabetes mellitus. By seamlessly integrating advanced machine learning pipelines into a unified, user-centric platform, this architecture effectively bridges the persistent gap between episodic clinical encounters and the necessity for continuous, proactive patient self-care. The synthesis of ensemble algorithms, specifically Random Forest, XGBoost, and Logistic Regression, establishes a robust foundation for accurate, non-invasive risk stratification based on foundational physiological metrics. Concurrently, the deployment of Long Short-Term Memory neural networks to process real-time Continuous Glucose Monitoring data elevates the application from a passive logging tool to an active predictive mechanism, granting patients the crucial foresight required to preempt severe glycemic excursions. Furthermore, the hybrid diet recommendation engine ensures that algorithmic interventions remain strictly anchored to established clinical guidelines while adapting to individual metabolic profiles. The true transformative potential of this mobile health solution, however, lies in its conversational chatbot interface and responsive component-driven frontend architecture. By translating complex, multidimensional predictive outputs into highly contextualized, natural language guidance, the application directly addresses the profound health literacy barriers that frequently hinder chronic disease management. The React-based implementation ensures that these vital insights are delivered with zero latency, fostering an engaging, empathetic digital therapeutic environment that actively encourages patient compliance. Moving forward, the natural progression of this research necessitates rigorous, longitudinal clinical trials to quantify the application\'s long-term efficacy on systemic glycemic control and Hemoglobin A1c reduction across diverse patient demographics. Future iterations must also focus on seamless integration with broader Electronic Health Record systems and the incorporation of multimodal wearable sensor data. Ultimately, this comprehensive integration of predictive analytics and conversational artificial intelligence establishes a highly scalable, patient-empowering blueprint that holds the potential to redefine the standard of care for diabetes and other chronic metabolic conditions.

References

[1] Alsayed, A., Ismail, N., Hasan, L., Syed, A., Embarak, F., & Da\'u, A. (2023). A systematic literature review for understanding the effectiveness of advanced techniques in diabetes self-care management. Alexandria Engineering Journal, 79, 274-295. https://doi.org/10.1016/j.aej.2023.08.026 [2] Bian, Q., As\'arry, A., Cong, X., Rezali, K. A. M., & Raja Ahmad, R. M. K. (2024). A hybrid Transformer-LSTM model apply to glucose prediction. PLOS One, 19(9), e0310084. https://doi.org/10.1371/journal.pone.0310084 [3] Carvalho, C. F., & Liang, Z. (2024). Glucose Prediction with Long Short-Term Memory (LSTM) Models in Three Distinct Populations. Engineering Proceedings, 82(1), 87. https://doi.org/10.3390/ecsa-11-20513 [4] Daghistani, T., & Alshammari, R. (2020). Comparison of Statistical and Machine Learning Techniques in Predicting Diabetes. Journal of Healthcare Engineering, 2020, 3936180. https://doi.org/10.1155/2020/3936180 [5] Hossain, M. A., et al. (2025). DiabetIQ: An Intelligent Diabetes Management Application with an Integrated LLM-Augmented RAG Chatbot and ML-Based Risk Early Prediction. ResearchGate Preprints. [6] Jeon, S., Lee, S., Kim, E. H., Eun, J., Lee, K., Lim, H., & Lee, J. (2025). Generative AI Chatbot for Diabetes Management: Formative 2-Part Qualitative Study Using DTalksBot Involving Patients and Clinicians. JMIR Formative Research, 9, e72553. https://doi.org/10.2196/72553 [7] Syed, A., et al. (2025). My diabetes care: an AI-based mobile app with conversational agent for type 2 diabetes self-management. Scientific Reports, 15. https://pmc.ncbi.nlm.nih.gov/articles/PMC12623767/ [8] Tuama, M., et al. (2025). Performance Comparison of Random Forest and XGBoost for Diabetes Prediction. International Journal of Science and Advanced Technology, 4. [9] Wu, Y., Zhang, J., Ge, P., Duan, T., Zhou, J., Wu, Y., Zhang, Y., Liu, S., Liu, X., Wan, E., & Sun, X. (2024). Application of Chatbots to Help Patients Self-Manage Diabetes: Systematic Review and Meta-Analysis. Journal of Medical Internet Research, 26, e60380. https://doi.org/10.2196/60380. [10] Wiens M, Verone-Boyle A, Henscheid N, Podichetty JT, Burton J. A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications. Clin Transl Sci. 2025 Mar;18(3):e70172. doi: 10.1111/cts.70172. PMID: 40067353; PMCID: PMC11895769. [11] Mirshekarian S, Bunescu R, Marling C, Schwartz F. Using LSTMs to learn physiological models of blood glucose behavior. Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:2887-2891. doi: 10.1109/EMBC.2017.8037460. PMID: 29060501; PMCID: PMC7888239. [12] Alex X. Wang, Viet-Tuan Le, Hau Nguyen Trung, Binh P. Nguyen, Addressing imbalance in health data: Synthetic minority oversampling using deep learning, Computers in Biology and Medicine, Volume 188, 2025, 109830, ISSN 0010-4825, https://doi.org/10.1016/j.compbiomed.2025.109830. (https://www.sciencedirect.com/science/article/pii/S0010482525001805). [13] Dixon D, Sattar H, Moros N, Kesireddy SR, Ahsan H, Lakkimsetti M, Fatima M, Doshi D, Sadhu K, Junaid Hassan M. Unveiling the Influence of AI Predictive Analytics on Patient Outcomes: A Comprehensive Narrative Review. Cureus. 2024 May 9;16(5):e59954. doi: 10.7759/cureus.59954. PMID: 38854327; PMCID: PMC11161909.

Copyright

Copyright © 2026 Jaseena OV, Dr. M Sukanya. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.